DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,217,000 | +103.2% | 60,386 | +276.1% | 0.00% | – |
| Q2 2021 | $599,000 | +62.3% | 16,054 | +11.5% | 0.00% | – |
| Q1 2021 | $369,000 | +14.2% | 14,396 | -2.0% | 0.00% | – |
| Q4 2020 | $323,000 | +21.9% | 14,691 | -0.6% | 0.00% | – |
| Q3 2020 | $265,000 | -40.8% | 14,783 | -16.2% | 0.00% | – |
| Q2 2020 | $448,000 | +56.6% | 17,645 | +13.4% | 0.00% | – |
| Q1 2020 | $286,000 | -27.0% | 15,557 | -12.6% | 0.00% | – |
| Q4 2019 | $392,000 | +100.0% | 17,808 | +30.3% | 0.00% | – |
| Q3 2019 | $196,000 | +28.9% | 13,666 | +41.6% | 0.00% | – |
| Q2 2019 | $152,000 | +7.8% | 9,649 | 0.0% | 0.00% | – |
| Q1 2019 | $141,000 | +43.9% | 9,649 | +5.0% | 0.00% | – |
| Q4 2018 | $98,000 | -3.0% | 9,186 | +38.7% | 0.00% | – |
| Q3 2018 | $101,000 | +24.7% | 6,625 | 0.0% | 0.00% | – |
| Q2 2018 | $81,000 | – | 6,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,930,237 | $85,373,000 | 50.34% |
| RTW INVESTMENTS, LP | 5,029,462 | $48,082,000 | 4.58% |
| EcoR1 Capital, LLC | 4,764,447 | $45,548,000 | 4.57% |
| RA Capital Management | 3,933,489 | $37,604,000 | 2.88% |
| Cormorant Asset Management, LP | 3,600,954 | $34,425,000 | 2.57% |
| Omega Fund Management, LLC | 223,457 | $2,136,000 | 2.10% |
| Ghost Tree Capital, LLC | 950,000 | $9,082,000 | 1.84% |
| EMORY UNIVERSITY | 246,411 | $2,356,000 | 1.68% |
| Trustees of Princeton University | 114,286 | $1,093,000 | 1.63% |
| BRIDGER MANAGEMENT, LLC | 1,226,820 | $11,728,000 | 0.71% |